#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Autoimmune haemolytic anaemia Facioscapulohumeral muscular dystrophy Hodgkin's disease refractory Cardiac failure acute Eosinophilic granulomatosis with polyangiitis Cutaneous T-cell lymphoma refractory Multiple system atrophy Fibrodysplasia ossificans progressiva Macular telangiectasia Medulloblastoma Atopic keratoconjunctivitis Oesophageal carcinoma Soft tissue sarcoma T-cell type acute leukaemia Wolfram syndrome More trials…

    Learn about Rare Diseases

    Gaucher’s disease type I – Treatment Piriformis syndrome – Life with Disease Pemphigus – Life with Disease Waldenstrom’s macroglobulinaemia recurrent – Basic Information Small intestine leiomyosarcoma – Life with Disease Friedreich’s ataxia – Trials in Disease Cytokine release syndrome – Basic Information Metachromatic leukodystrophy – Diagnostics Prader-Willi syndrome – Treatment Paroxysmal nocturnal haemoglobinuria – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Spartalizumab Acetazolamide Sodium Anselamimab VGA039 NORETHISTERONE ACETATE 18F-Psma-1007 Avapritinib Paracetamol Ph. Eur. Aclidinium Bromide Dexrazoxane Hydrochloride Rosuvastatin Pantoprazole Ciclesonide Rifampicin Blinatumomab Relacorilant Cimetidine Satoreotide Tetraxetan Tryptophan Plasma More therapies…

    Learn about Your Condition

    Breast cancer female Gingival bleeding Viral myocarditis Chronic kidney disease Cardiac failure chronic Pulmonary fibrosis Toxicity to various agents Genital infection female Diabetes mellitus Dyskinesia Muscle spasticity Pre-eclampsia Hand dermatitis Arterial stiffness Epithelioid sarcoma More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Thyroid cancer

  • A study comparing how lenvatinib capsules are absorbed in the body in healthy volunteers under fasting and fed conditions

    Not recruiting

    1 1 1 1
    Investigated Diseases:
    • Thyroid cancer
    • Endometrial cancer
    • Hepatocellular carcinoma
    Investigated Drugs:
    • Lenvatinib
    Portugal
  • Study on Cabozantinib for Patients with Advanced Radioactive-Iodine Refractory Differentiated Thyroid Cancer

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Thyroid cancer
    Investigated Drugs:
    • Cabozantinib
    Spain
  • Study of JK08, Pembrolizumab, and Lenvatinib for Patients with Advanced or Metastatic Cancer

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Thyroid cancer
    • Transitional cell cancer of the renal pelvis and ureter
    • Cervix carcinoma
    Investigated Drugs:
    • Jk08
    • Lenvatinib
    • Pembrolizumab
    Belgium Spain
  • Study of Cabozantinib in Adults with Progressive Thyroid Cancer Who Did Not Respond to Previous Treatment with Radioactive Iodine and VEGFR Therapy

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Thyroid cancer
    Investigated Drugs:
    • Cabozantinib
    Poland Romania Spain
Previous Page
1 2

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.


European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.

Numer nieprawidłowy!
Numer nieprawidłowy!